Recent filings by Charles River Laboratories International, Inc.

Published Title Summary
2026-04-29 17:49:15 SCHEDULE 13G - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Subject) Passive 5% Ownership Report SEC-SCHEDULE 13G filed by Charles River...
Passive 5% Ownership Report SEC-SCHEDULE 13G filed by Charles River Laboratories International, Inc. on 2026-04-29 17:49:15-04:00
2026-03-05 17:18:17 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2026-03-05 17:18:17-05:00
2026-03-04 16:42:20 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2026-03-04 16:42:20-05:00
2026-03-04 16:39:28 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2026-03-04 16:39:28-05:00
2026-02-25 07:34:10 8-K - Current report Filed: 2026-02-25 AccNo: 0001628280-26-011395 Size: 160 KB
Item 7.01: Regulation FD...
Filed: 2026-02-25 AccNo: 0001628280-26-011395 Size: 160 KB
Item 7.01: Regulation FD Disclosure
2026-02-18 16:39:47 8-K - Current report Filed: 2026-02-18 AccNo: 0000950103-26-002326 Size: 225 KB
Item 5.02: Departure of...
Filed: 2026-02-18 AccNo: 0000950103-26-002326 Size: 225 KB
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits
2026-02-18 09:21:09 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Annual Report SEC-10-K filed by Charles River Laboratories International, Inc....
Annual Report SEC-10-K filed by Charles River Laboratories International, Inc. on 2026-02-18 09:21:09-05:00
2026-02-18 07:13:34 8-K - Current report Filed: 2026-02-18 AccNo: 0001100682-26-000020 Size: 691 KB
Item 2.02: Results of...
Filed: 2026-02-18 AccNo: 0001100682-26-000020 Size: 691 KB
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits
2026-02-12 13:51:37 SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors Passive 5% Ownership Report SEC-SCHEDULE 13G filed by Charles River...
Passive 5% Ownership Report SEC-SCHEDULE 13G filed by Charles River Laboratories International, Inc. on 2026-02-12 13:51:37-05:00
2026-02-03 16:36:02 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2026-02-03 16:36:02-05:00
2026-02-03 16:33:42 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2026-02-03 16:33:42-05:00
2026-02-02 16:46:30 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2026-02-02 16:46:30-05:00
2026-02-02 16:42:36 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2026-02-02 16:42:36-05:00
2026-02-02 16:39:56 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2026-02-02 16:39:56-05:00
2026-02-02 16:36:22 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2026-02-02 16:36:22-05:00
2026-02-02 16:32:20 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2026-02-02 16:32:20-05:00
2026-01-20 08:49:50 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2026-01-20 08:49:50-05:00
2026-01-13 08:10:36 8-K - Current report Filed: 2026-01-13 AccNo: 0001628280-26-001905 Size: 156 KB
Item 2.02: Results of...
Filed: 2026-01-13 AccNo: 0001628280-26-001905 Size: 156 KB
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
2026-01-09 16:18:18 8-K - Current report Filed: 2026-01-09 AccNo: 0001628280-26-001603 Size: 142 KB
Item 5.02: Departure of...
Filed: 2026-01-09 AccNo: 0001628280-26-001603 Size: 142 KB
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
2025-12-03 07:28:50 8-K - Current report Filed: 2025-12-03 AccNo: 0001628280-25-054902 Size: 141 KB
Item 7.01: Regulation FD...
Filed: 2025-12-03 AccNo: 0001628280-25-054902 Size: 141 KB
Item 7.01: Regulation FD Disclosure
2025-11-17 08:06:40 8-K - Current report Filed: 2025-11-17 AccNo: 0001628280-25-052484 Size: 136 KB
Item 8.01: Other Events...
Filed: 2025-11-17 AccNo: 0001628280-25-052484 Size: 136 KB
Item 8.01: Other Events
2025-11-07 16:35:20 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2025-11-07 16:35:20-05:00
2025-11-05 09:12:06 10-Q - Quarterly report [Sections 13 or 15(d)] Quarterly Report SEC-10-Q filed by Charles River Laboratories International, Inc....
Quarterly Report SEC-10-Q filed by Charles River Laboratories International, Inc. on 2025-11-05 09:12:06-05:00
2025-11-05 07:16:00 8-K - Current report Filed: 2025-11-05 AccNo: 0001100682-25-000041 Size: 671 KB
Item 2.02: Results of...
Filed: 2025-11-05 AccNo: 0001100682-25-000041 Size: 671 KB
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits
2025-09-16 07:10:48 8-K - Current report Filed: 2025-09-16 AccNo: 0000950103-25-011676 Size: 222 KB
Item 5.02: Departure of...
Filed: 2025-09-16 AccNo: 0000950103-25-011676 Size: 222 KB
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits
2025-08-20 16:45:35 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2025-08-20 16:45:35-04:00
2025-08-14 17:41:14 SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors Passive 5% Ownership Report SEC-SCHEDULE 13G filed by Charles River...
Passive 5% Ownership Report SEC-SCHEDULE 13G filed by Charles River Laboratories International, Inc. on 2025-08-14 17:41:14-04:00
2025-08-08 16:18:55 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Charles River Laboratories International, Inc. on 2025-08-08 16:18:55-04:00
2025-08-06 09:07:31 10-Q - Quarterly report [Sections 13 or 15(d)] Quarterly Report SEC-10-Q filed by Charles River Laboratories International, Inc....
Quarterly Report SEC-10-Q filed by Charles River Laboratories International, Inc. on 2025-08-06 09:07:31-04:00
2025-08-06 07:08:41 8-K - Current report Filed: 2025-08-06 AccNo: 0001100682-25-000032 Size: 652 KB
Item 2.02: Results of...
Filed: 2025-08-06 AccNo: 0001100682-25-000032 Size: 652 KB
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits